Bronchopulmonary dysplasia - Impact of surfactant replacement therapy

被引：11
|
作者：
McColley, SA
机构：
[1] Northwestern Univ, Sch Med, Div Pediat Pulm & Crit Care Med, Chicago, IL USA
[2] Childrens Mem Med Ctr, Cyst Fibrosis Ctr, Chicago, IL USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 1998年 / 45卷 / 03期
关键词：
D O I：
10.1016/S0031-3955(05)70028-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Bronchopulmonary dysplasia is a major contributor to the morbidity and mortality of infants born prematurely. Surfactant replacement therapy has had a significant impact on the death rate from respiratory distress syndrome, yet the impact on bronchopulmonary dysplasia is minimal. Despite these findings, the overall incidence and severity of bronchopulmonary dysplasia are likely to decline over time as neonatal care continues to advance.
引用
收藏
页码：573 / +
页数：15
相关论文
共 50 条
  • [21] Surfactant metabolism in preterm infants with bronchopulmonary dysplasia (BPD)
    Zozobrado, J
    Bohlin, K
    Patterson, B
    Hamvas, A
    Spence, K
    PEDIATRIC RESEARCH, 2003, 53 (04) : 434A - 434A
  • [22] Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia
    Yeh, Tsu F.
    Chen, Chung M.
    Wu, Shou Y.
    Husan, Zahid
    Li, Tsai C.
    Hsieh, Wu S.
    Tsai, Chang H.
    Lin, Hung C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (01) : 86 - 95
  • [23] THE EFFECT OF SURFACTANT REPLACEMENT THERAPY ON CONDITIONS ASSOCIATED WITH RESPIRATORY-DISTRESS SYNDROME - PATENT DUCTUS-ARTERIOSUS, INTRAVENTRICULAR HEMORRHAGE, AND BRONCHOPULMONARY DYSPLASIA
    KENDIG, JW
    SINKIN, RA
    SEMINARS IN PERINATOLOGY, 1988, 12 (03) : 255 - 258
  • [24] Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy
    Lui, K
    Lloyd, J
    Ang, E
    Rynn, M
    Gupta, JM
    PEDIATRIC PULMONOLOGY, 2000, 30 (04) : 282 - 290
  • [25] MINIMALLY INVASIVE SURFACTANT THERAPY (MIST) TO REDUCE BRONCHOPULMONARY DYSPLASIA (BPD): A QUALITY IMPROVEMENT PROJECT
    Razdan, S.
    Gu, H.
    Bain, L.
    Davis, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 677 - 678
  • [26] DEXAMETHASONE THERAPY IN SEVERE BRONCHOPULMONARY DYSPLASIA
    BOURCHIER, D
    AUSTRALIAN PAEDIATRIC JOURNAL, 1988, 24 (01): : 41 - 44
  • [27] ANTENATAL INDOMETHACIN THERAPY AND BRONCHOPULMONARY DYSPLASIA
    LEMKE, RP
    SAEDI, SA
    CASIRO, O
    SAVANI, RC
    JOURNAL OF PEDIATRICS, 1995, 127 (01): : 160 - 160
  • [28] Is there a role for antioxidant therapy in bronchopulmonary dysplasia?
    Welty, SE
    JOURNAL OF NUTRITION, 2001, 131 (03): : 947S - 950S
  • [29] The economic impact of prematurity and bronchopulmonary dysplasia
    Alvarez-Fuente, Maria
    Arruza, Luis
    Muro, Marta
    Zozaya, Carlos
    Avila, Alejandro
    Lopez-Ortego, Paloma
    Gonzalez-Armengod, Carmen
    Torrent, Alba
    Luis Gavilan, Jose
    Jesus del Cerro, Maria
    EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (12) : 1587 - 1593
  • [30] AMNION CELL THERAPY FOR BRONCHOPULMONARY DYSPLASIA
    Lim, R.
    Malhotra, A.
    Lau, S.
    Mockler, J.
    Wallace, E.
    CYTOTHERAPY, 2016, 18 (06) : S23 - S23
12345